Goldman Sachs Group set a €29.00 ($33.72) price target on AXA (EPA:CS) in a report issued on Monday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Other equities research analysts also recently issued research reports about the stock. Jefferies Financial Group set a €24.30 ($28.26) price objective on shares of AXA and gave the stock a buy rating in a research note on Wednesday, November 6th. Nord/LB set a €27.00 ($31.40) price objective on shares of AXA and gave the stock a buy rating in a research note on Tuesday, August 27th. JPMorgan Chase & Co. set a €26.90 ($31.28) price objective on shares of AXA and gave the stock a buy rating in a research note on Wednesday, November 6th. Barclays set a €24.30 ($28.26) price objective on shares of AXA and gave the stock a neutral rating in a research note on Thursday, October 24th. Finally, Morgan Stanley set a €26.70 ($31.05) price objective on shares of AXA and gave the stock a buy rating in a research note on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. AXA currently has an average rating of Buy and an average target price of €26.67 ($31.01).

EPA:CS opened at €24.61 ($28.61) on Monday. AXA has a 12 month low of €22.13 ($25.73) and a 12 month high of €27.69 ($32.20). The company’s 50 day moving average is €24.52 and its 200-day moving average is €23.07.

AXA Company Profile

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Recommended Story: Why investors pay attention to retained earnings

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.